Omada Health (OMDA) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	309.8M	260.2M	169.8M	122.8M	89.2M
Cost of Revenue	98.5M	89.3M	66.9M	52.8M	46.4M
Gross Profit	211.2M	170.9M	102.9M	70.0M	42.8M
Operating Expenses
R&D Expense	37.2M	40.7M	35.9M	33.7M	26.2M
SG&A Expense	125.1M	142.2M	110.6M	102.2M	89.0M
General & Admin Expense	46.3M	52.2M	42.6M	36.0M	30.5M
Selling & Marketing Expense	78.9M	90.0M	68.1M	66.2M	58.5M
Other Expenses	49.3M	—	—	—	—
Total Operating Expenses	211.7M	182.9M	146.5M	136.0M	115.1M
Cost and Expenses	310.2M	272.2M	213.5M	188.8M	161.5M
Operating Income (EBIT)	(464.0K)	(12.0M)	(43.7M)	(66.0M)	(72.3M)
Non-Operating
Interest Income	7.5M	5.3M	805.0K	5.8M	2.2M
Interest Expense	398.0K	2.5M	4.5M	4.7M	4.2M
Net Interest Income	7.1M	2.8M	(3.7M)	1.1M	(2.0M)
Other Non-Op Income/Expense	4.8M	(806.0K)	(3.5M)	(1.5M)	(168.0K)
Non-Operating Income (excl Interest)	(4.8M)	(1.7M)	(1.0M)	(3.2M)	(4.0M)
EBT (Pre-Tax Income)	4.3M	(12.8M)	(47.1M)	(67.5M)	(72.5M)
Income Tax Expense	—	—	—	—	—
Bottom Line
Net Income	4.3M	(12.8M)	(47.1M)	(67.5M)	(72.5M)
Earnings from Cont. Ops	4.3M	(12.8M)	(47.1M)	(67.5M)	(72.5M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	4.3M	(12.8M)	(47.1M)	(67.5M)	(72.5M)
Per Share
Basic EPS	$0.07	($0.22)	($0.85)	($1.21)	($1.30)
Diluted EPS	$0.06	($0.22)	($0.85)	($1.21)	($1.30)
Revenue Per Share	$5.19	$4.45	$3.05	$2.20	$1.60
Shares
Basic Shares Outstanding	59.7M	58.4M	55.7M	55.7M	55.7M
Diluted Shares Outstanding	63.9M	58.4M	55.7M	55.7M	55.7M
Profitability Metrics
EBITDA	11.8M	(4.8M)	(37.8M)	(58.4M)	(64.0M)
D&A	7.4M	5.5M	4.8M	4.4M	4.3M
EBIT	4.3M	(10.2M)	(42.6M)	(62.8M)	(68.3M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026